Cargando…

Dynamics of Epithelial–Mesenchymal Plasticity: What Have Single-Cell Investigations Elucidated So Far?

[Image: see text] Epithelial–mesenchymal plasticity (EMP) is a key driver of cancer metastasis and therapeutic resistance, through which cancer cells can reversibly and dynamically alter their molecular and functional traits along the epithelial–mesenchymal spectrum. While cells in the epithelial ph...

Descripción completa

Detalles Bibliográficos
Autores principales:	Subhadarshini, Seemadri, Markus, Joel, Sahoo, Sarthak, Jolly, Mohit Kumar
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Chemical Society 2023
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10077445/ https://www.ncbi.nlm.nih.gov/pubmed/37033874 http://dx.doi.org/10.1021/acsomega.2c07989

Ejemplares similares

Dynamical modelling of proliferative-invasive plasticity and IFNγ signaling in melanoma reveals mechanisms of PD-L1 expression heterogeneity
por: Subhadarshini, Seemadri, et al.
Publicado: (2023)

Dynamical modeling of proliferative-invasive plasticity and IFNγ signaling in melanoma reveals mechanisms of PD-L1 expression heterogeneity
por: Subhadarshini, Seemadri, et al.
Publicado: (2023)

Quantifying the Patterns of Metabolic Plasticity and Heterogeneity along the Epithelial–Hybrid–Mesenchymal Spectrum in Cancer
por: Muralidharan, Srinath, et al.
Publicado: (2022)

COVID-19: What We Have Learned So Far
por: Clifford, Theresa
Publicado: (2020)

Pediatric Myocarditis: What Have We Learnt So Far?
por: Pomiato, Elettra, et al.
Publicado: (2022)

The hypocretins and the reward function: what have we learned so far?
por: Boutrel, Benjamin, et al.
Publicado: (2013)

Brain Tumor Immunotherapy: What have We Learned so Far?
por: Van Gool, Stefaan Willy
Publicado: (2015)

Editorial: Cancer Nanotheranostics: What Have We Learned So Far?
por: Conde, João, et al.
Publicado: (2016)

OMICs in Cariology and Endodontology – what have we learned so far?
por: Zaura, Egija
Publicado: (2017)

Circadian Clocks in Fish—What Have We Learned so far?
por: Frøland Steindal, Inga A., et al.
Publicado: (2019)

Offline: COVID-19—what have we learned so far?
por: Horton, Richard
Publicado: (2020)

What have we learnt so far from COVID-19?
por: Doherty, Peter C.
Publicado: (2021)

Bleeding in COVID Patients: What We Have Understood So Far
por: Lucatelli, Pierleone, et al.
Publicado: (2021)

Ovarian Cancer Radiosensitivity: What Have We Understood So Far?
por: Barcellini, Amelia, et al.
Publicado: (2022)

ECMO Retrieval Program: What Have We Learned So Far
por: Krasivskyi, Ihor, et al.
Publicado: (2023)

COVID-19 and the heart: what we have learnt so far
por: Shaha, Kunal Bikram, et al.
Publicado: (2020)

Immunosuppressive Traits of the Hybrid Epithelial/Mesenchymal Phenotype
por: Sahoo, Sarthak, et al.
Publicado: (2021)

Epithelial/mesenchymal plasticity: how have quantitative mathematical models helped improve our understanding?
por: Jolly, Mohit Kumar, et al.
Publicado: (2017)

Mesenchymal stromal cells: what have we learned so far about their therapeutic potential and mechanisms of action?
por: Amadeo, Francesco, et al.
Publicado: (2021)

Campylobacter Phage Isolation and Characterization: What We Have Learned So Far
por: Jäckel, Claudia, et al.
Publicado: (2019)

Editorial: Cancer Epidemiology in China: What We Have Learnt So Far?
por: Chen, Tianhui, et al.
Publicado: (2020)

MRD Tailored Therapy in AML: What We Have Learned So Far
por: Ngai, Lok Lam, et al.
Publicado: (2021)

Sarcopenia in chronic kidney disease: what have we learned so far?
por: Sabatino, Alice, et al.
Publicado: (2020)

European birth cohorts: a consideration of what they have addressed so far
por: Pandolfini, Chiara, et al.
Publicado: (2022)

What we know so far
Publicado: (2021)

Toxicity and cellular uptake of gold nanoparticles: what we have learned so far?
por: Alkilany, Alaaldin M., et al.
Publicado: (2010)

Neural synchrony within the motor system: what have we learned so far?
por: van Wijk, Bernadette C. M., et al.
Publicado: (2012)

NEO adjuvant chemotherapy in breast cancer: What have we learned so far?
por: Raut, Nirmal V, et al.
Publicado: (2010)

Combining inclusive and exclusive data analyses-what have we learned so far?
por: Kittel, E W
Publicado: (1973)

Theory: Historical perspective and what have we learned from the Higgs so far
por: Ellis, Jonathan R.
Publicado: (2022)

Mitochondrial Neurogastrointestinal Encephalomyopathy: Into the Fourth Decade, What We Have Learned So Far
por: Pacitti, Dario, et al.
Publicado: (2018)

The COVID-19 Pandemic and Cardiovascular Complications: What Have We Learned So Far?
por: Walsh, Mary Norine, et al.
Publicado: (2020)

Gene Therapy in Rare Respiratory Diseases: What Have We Learned So Far?
por: Bañuls, Lucía, et al.
Publicado: (2020)

More on the MORE Life Experience Model: What We Have Learned (So Far)
por: Glück, Judith, et al.
Publicado: (2018)

Role of Gut Dysbiosis in Liver Diseases: What Have We Learned So Far?
por: Fukui, Hiroshi
Publicado: (2019)

Proteomics of Rice—Magnaporthe oryzae Interaction: What Have We Learned So Far?
por: Meng, Qingfeng, et al.
Publicado: (2019)

Implementation of the Nagoya Protocol in Livestock Sector: What Have We Learnt So Far?
por: Martyniuk, Elzbieta, et al.
Publicado: (2021)

Feline Morbillivirus Infection in Domestic Cats: What Have We Learned So Far?
por: De Luca, Eliana, et al.
Publicado: (2021)

Twenty years of mini-laparoscopy in Brazil: What we have learned so far
por: Lima, Diego Laurentino, et al.
Publicado: (2021)

Genetic Biomarkers in Chronic Myeloid Leukemia: What Have We Learned So Far?
por: Abdulmawjood, Bilal, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_bnpq78c0m6apd0om64bt500adk